Pharmaceutical company Qnovia partners with the University of Virginia (UVA) to create inhaled drugs for lung infections, bolstering their development pipeline with assets for pneumonia and biodefense-related pulmonary infections.
A top official at Turnitin’s parent company Advance, said it was ending its relationship with SIIA over the association’s opposition to the Journalism Competition and Preservation Act.
What s Next In Smoking Cessation Therapies A QA With Qnovia CEO Brian Quigley And Advisor Mitch Zeller clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Company plans to pursue UK authorization in parallel to approval in the U.S. Qnovia, Inc. ("Qnovia"), a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement